Filing Details
- Accession Number:
- 0001171843-14-003848
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-08-08 19:06:37
- Reporting Period:
- 2014-08-07
- Filing Date:
- 2014-08-08
- Accepted Time:
- 2014-08-08 19:06:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 3116 | Akorn Inc | AKRX | Pharmaceutical Preparations (2834) | 720717400 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1234734 | Rajat Rai | 1925 West Field Court Suite 300 Lake Forest IL 60045 | Chief Executive Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-08-07 | 2,000,000 | $1.34 | 2,031,271 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-08-07 | 903,659 | $33.62 | 1,127,612 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-08-07 | 250,000 | $0.00 | 250,000 | $1.34 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-08-07 | 1,750,000 | $0.00 | 1,750,000 | $1.34 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-12-07 | 2014-08-07 | No | 4 | M | Direct |
| 0 | 2014-08-07 | No | 4 | M | Direct |
Footnotes
- Proceeds from the sale were used to pay exercise price and taxes due upon exercise of options.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $33.14 to $34.11 per share. The reporting person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at separate prices within the foregoing range.
- Amount of Shares Beneficially Owned Following Reported Transaction includes 26,271 unvested shares subject to a restricted stock award and 1,101,341 shares owned outright.
- Exercise of stock options that were approaching their 5-year expiration date.
- There was no consideration given in exchange for the security.
- 1,750,000 options vested upon shareholder approval of an amendment to plan and the 6 month renewals of reporting person's consulting agreement which expired on December 7, 2009 pursuant to the following vesting schedule: 250,000 options vested upon each subsequent 6 month renewal of reporting person's consulting agreement after December 7, 2009 to June 7, 2013.
Billionaire Hedge Funds
